JDOCvsPBPHETF Comparison
Portfolio Building Block World Pharma and Biotech Index ETF
JPMorgan Healthcare Leaders ETF (JDOC) belongs to the Global Blended Cap segment. Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) is part of the DM Large & Mid Cap segment. Both ETFs have the same top 3 sector exposures: and Health Care. JDOC is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.13% for PBPH. JDOC is down -0.35% year-to-date (YTD) with -$34K in YTD flows. PBPH performs better with 2.87% YTD performance, and +$830M in YTD flows. Run a side-by-side ETF comparison of JDOC and PBPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
JDOC vs PBPH performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | JDOC PBPH | +3.22%+3.38% | +3.29%+1.37% | -0.35%+2.87% | +13.56%n/a | n/an/a | n/an/a |
| Flows | JDOC PBPH | -$3M+$25M | -$34K+$95M | -$34K+$830M | -$34K- | -- | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | JDOC PBPH | +16.43%+17.19% | +14.34%n/a | n/an/a | n/an/a |
| Max drawdown | JDOC PBPH | -4.72%-5.84% | -9.66%n/a | n/an/a | n/an/a |
| Max drawdown duration | JDOC PBPH | 50d56d | 141dn/a | n/an/a | n/an/a |
JDOC | PBPH | |
Last sale 6/12/2026 at 1:30 PM | $57.58 | $25.97 |
| Previous close 06/11/2026 | $57.67 | $26.08 |
| Consolidated volume 06/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
JDOC | PBPH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
JDOC | PBPH | |
|---|---|---|
| Last price | $57.58 | $25.97 |
| 1D performance | -0.16% | -0.44% |
| AuM | $8.65 M | $812.18 M |
| E/R | 0.65% | 0.13% |
JDOC | PBPH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | J.P. Morgan Asset Management | Tidal |
| Benchmark | - | BITA Global Pharma and Biotech Select Index |
| N° of holdings | 50 | 49 |
| Asset class | - | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 1, 2023 | November 24, 2025 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
